A detailed history of First Capital Advisors Group, Llc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 150 shares of FLGT stock, worth $3,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$3,133
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$28.52 - $40.7 $4,278 - $6,105
150 New
150 $5,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $632M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track First Capital Advisors Group, Llc. Portfolio

Follow First Capital Advisors Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.